CN103114132A - 一种用于检测宫颈癌致癌基因的引物探针、试剂盒及用于非检测疾病目的的检测方法 - Google Patents
一种用于检测宫颈癌致癌基因的引物探针、试剂盒及用于非检测疾病目的的检测方法 Download PDFInfo
- Publication number
- CN103114132A CN103114132A CN2012105606288A CN201210560628A CN103114132A CN 103114132 A CN103114132 A CN 103114132A CN 2012105606288 A CN2012105606288 A CN 2012105606288A CN 201210560628 A CN201210560628 A CN 201210560628A CN 103114132 A CN103114132 A CN 103114132A
- Authority
- CN
- China
- Prior art keywords
- probe
- extension probes
- detection
- amplification
- sequence seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 title claims abstract description 371
- 238000001514 detection method Methods 0.000 title claims abstract description 85
- 108700020796 Oncogene Proteins 0.000 title claims abstract description 43
- 206010008342 Cervix carcinoma Diseases 0.000 title claims abstract description 28
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 title claims abstract description 28
- 201000010881 cervical cancer Diseases 0.000 title claims abstract description 28
- 201000010099 disease Diseases 0.000 title claims abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 11
- 230000003321 amplification Effects 0.000 claims description 95
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 95
- 238000012360 testing method Methods 0.000 claims description 41
- 241000701806 Human papillomavirus Species 0.000 claims description 32
- 239000000758 substrate Substances 0.000 claims description 26
- 238000013016 damping Methods 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 21
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 238000011534 incubation Methods 0.000 claims description 19
- 108020004999 messenger RNA Proteins 0.000 claims description 19
- 238000002372 labelling Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 238000005336 cracking Methods 0.000 claims description 9
- 239000006166 lysate Substances 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 210000003679 cervix uteri Anatomy 0.000 claims description 6
- 241000341655 Human papillomavirus type 16 Species 0.000 claims description 5
- 239000013642 negative control Substances 0.000 claims description 5
- 210000000981 epithelium Anatomy 0.000 claims description 4
- 239000007790 solid phase Substances 0.000 claims description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 21
- 238000009396 hybridization Methods 0.000 abstract description 11
- 108020004707 nucleic acids Proteins 0.000 abstract description 5
- 102000039446 nucleic acids Human genes 0.000 abstract description 5
- 150000007523 nucleic acids Chemical class 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 4
- 229960000074 biopharmaceutical Drugs 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 32
- 108020004414 DNA Proteins 0.000 description 25
- 238000002156 mixing Methods 0.000 description 16
- 238000003908 quality control method Methods 0.000 description 14
- -1 and wherein Substances 0.000 description 13
- 241000700605 Viruses Species 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000009826 distribution Methods 0.000 description 9
- 239000003085 diluting agent Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000004744 fabric Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 239000003643 water by type Substances 0.000 description 6
- 238000013461 design Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 206010008263 Cervical dysplasia Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 101100450563 Mus musculus Serpind1 gene Proteins 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 241000701827 Human papillomavirus type 35 Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 208000037581 Persistent Infection Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005213 imbibition Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000005000 reproductive tract Anatomy 0.000 description 2
- 239000012723 sample buffer Substances 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 208000007879 Atypical Squamous Cells of the Cervix Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000780272 Mammilla Species 0.000 description 1
- 206010065764 Mucosal infection Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 201000006662 cervical adenocarcinoma Diseases 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000009841 epithelial lesion Effects 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 208000017572 squamous cell neoplasm Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
细胞学结果 | 宫颈稳态检测阳性 | 宫颈稳态检测阴性 | 总计 | 阳性率 |
阴性 | 291 | 1260 | 1551 | 19% |
ASC-US | 660 | 2110 | 2770 | 24% |
ASC-H | 201 | 280 | 481 | 42% |
LSIL | 580 | 361 | 941 | 62% |
HSIL* | 411 | 441 | 852 | 45% |
总计 | 2143 | 4452 | 6595 | 32% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210560628.8A CN103114132B (zh) | 2012-12-20 | 2012-12-20 | 一种用于检测宫颈癌致癌基因的引物探针、试剂盒及用于非检测疾病目的的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210560628.8A CN103114132B (zh) | 2012-12-20 | 2012-12-20 | 一种用于检测宫颈癌致癌基因的引物探针、试剂盒及用于非检测疾病目的的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103114132A true CN103114132A (zh) | 2013-05-22 |
CN103114132B CN103114132B (zh) | 2014-10-29 |
Family
ID=48412549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210560628.8A Active CN103114132B (zh) | 2012-12-20 | 2012-12-20 | 一种用于检测宫颈癌致癌基因的引物探针、试剂盒及用于非检测疾病目的的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103114132B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106498041A (zh) * | 2016-10-14 | 2017-03-15 | 浙江大学 | 一种用于检测宫颈癌的引物组及检测方法 |
CN108796134A (zh) * | 2018-07-12 | 2018-11-13 | 郑州科蒂亚生物技术有限公司 | 一种宫颈癌检测探针序列及其应用 |
CN109943665A (zh) * | 2019-04-15 | 2019-06-28 | 郑州科蒂亚生物技术有限公司 | 一种用于检测头颈鳞癌致癌基因检测的探针序列及其试剂盒、应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101017141A (zh) * | 2006-02-09 | 2007-08-15 | 港龙生物技术(深圳)有限公司 | 诊断人类乳头状病毒(hpv)感染的荧光聚合酶链式反应(pcr)的方法和试剂盒 |
CN101435002A (zh) * | 2008-12-12 | 2009-05-20 | 深圳华大基因科技有限公司 | 一种检测人类乳头瘤病毒基因型的方法 |
-
2012
- 2012-12-20 CN CN201210560628.8A patent/CN103114132B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101017141A (zh) * | 2006-02-09 | 2007-08-15 | 港龙生物技术(深圳)有限公司 | 诊断人类乳头状病毒(hpv)感染的荧光聚合酶链式反应(pcr)的方法和试剂盒 |
CN101435002A (zh) * | 2008-12-12 | 2009-05-20 | 深圳华大基因科技有限公司 | 一种检测人类乳头瘤病毒基因型的方法 |
Non-Patent Citations (1)
Title |
---|
王健等: "乙肝病毒血清标志物的检测方法及其临床意义", 《中华检验医学杂志》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106498041A (zh) * | 2016-10-14 | 2017-03-15 | 浙江大学 | 一种用于检测宫颈癌的引物组及检测方法 |
CN108796134A (zh) * | 2018-07-12 | 2018-11-13 | 郑州科蒂亚生物技术有限公司 | 一种宫颈癌检测探针序列及其应用 |
CN108796134B (zh) * | 2018-07-12 | 2021-09-10 | 郑州科蒂亚生物技术有限公司 | 一种宫颈癌检测探针序列及其应用 |
CN109943665A (zh) * | 2019-04-15 | 2019-06-28 | 郑州科蒂亚生物技术有限公司 | 一种用于检测头颈鳞癌致癌基因检测的探针序列及其试剂盒、应用 |
CN109943665B (zh) * | 2019-04-15 | 2023-05-16 | 郑州科蒂亚生物技术有限公司 | 一种用于检测头颈鳞癌致癌基因检测的探针序列及其试剂盒、应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103114132B (zh) | 2014-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lie et al. | Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma | |
Barcelos et al. | Atypical squamous cells of undetermined significance: Bethesda classification and association with Human Papillomavirus | |
Dong et al. | Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case–control study | |
CN102154524B (zh) | 12+2高危型人乳头状瘤病毒核酸检测试剂盒 | |
Satoh et al. | Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test (Clinichip HPV™) | |
Alhamlan et al. | Current studies on human papillomavirus in Saudi Arabia | |
del Pino et al. | Clinical, colposcopic and pathological characteristics of cervical and vaginal high-grade lesions negative for HPV by Hybrid Capture 2 | |
Tao et al. | Sensitive HPV genotyping based on the flow‐through hybridization and gene chip | |
Kreuter et al. | Expression of proliferative biomarkers in anal intraepithelial neoplasia of HIV-positive men | |
CN103725792A (zh) | 人类乳头瘤病毒(24型)检测(荧光pcr法)试剂盒及其检测方法 | |
Halfon et al. | Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ® HPV assay | |
CN104017907B (zh) | 一种hpv高危型荧光pcr检测试剂盒 | |
CN105755169A (zh) | 一种高危型人乳头瘤病毒的检测和分型试剂盒及其应用 | |
Nakamura et al. | HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study | |
Roy-Chowdhuri et al. | The role of cytology in the era of HPV-related head and neck carcinoma | |
CN104017906B (zh) | 一种hpv高危型分型荧光pcr检测试剂盒 | |
Jaworek et al. | A head-to-head analytical comparison of Cobas 4800 HPV, PapilloCheck HPV Screening, and LMNX Genotyping Kit HPV GP for detection of human papillomavirus DNA in cervical and cervicovaginal swabs | |
CN103114132B (zh) | 一种用于检测宫颈癌致癌基因的引物探针、试剂盒及用于非检测疾病目的的检测方法 | |
CN101503741A (zh) | 用于检测高危型人乳头瘤病毒的试剂盒及其制备和应用 | |
Wang et al. | Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China | |
CN112575123B (zh) | 引物组合、探针组合以及人乳头瘤病毒核酸检测试剂盒 | |
CN106048081A (zh) | 一种hpv分型检测引物及其检测方法和应用 | |
CN108179226A (zh) | 一种检测人乳头瘤病毒的核酸组合及其应用和试剂盒 | |
CN108085419B (zh) | 探针及引物组合物 | |
Fokom Domgue et al. | Assessment of a new lower-cost real-time PCR assay for detection of high-risk human papillomavirus: useful for cervical screening in limited-resource settings? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: ZHANG AIGUO LIU TONGYU Effective date: 20141201 Owner name: KODIA (XINXIANG) BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHANG LULU Effective date: 20141201 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Lulu Inventor after: Liu Tongyu Inventor before: Zhang Lulu Inventor before: Zhang Aiguo Inventor before: Liu Tongyu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG LULU ZHANG AIGUO LIU TONGYU TO: ZHANG LULU LIU TONGYU Free format text: CORRECT: ADDRESS; TO: 453000 XINXIANG, HENAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141201 Address after: Zhang San Zhai Wei Changyuan County of Xinxiang City, Henan province 453000 Industrial Park. Patentee after: KODIA (XINXIANG) BIOLOGICAL TECHNOLOGY CO.,LTD. Address before: No. 3535, breakwater Avenue, Hayward, California Patentee before: Zhang Lulu Patentee before: Zhang Aiguo Patentee before: Liu Tongyu |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161209 Address after: 450001 Henan city of Zhengzhou province Zhengzhou high tech Industrial Development Zone Long Chun Road No. 11 Building 1 floor 2 No. A2 Patentee after: ZHENGZHOU AISIYA BIOTECHNOLOGY CO.,LTD. Address before: Zhang San Zhai Wei Changyuan County of Xinxiang City, Henan province 453000 Industrial Park. Patentee before: KODIA (XINXIANG) BIOLOGICAL TECHNOLOGY CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 450001 Henan city of Zhengzhou province Zhengzhou high tech Industrial Development Zone Long Chun Road No. 11 Building 1 floor 2 No. A2 Patentee after: ZHENGZHOU KODIA BIOTECHNOLOGY CO.,LTD. Address before: 450001 Henan city of Zhengzhou province Zhengzhou high tech Industrial Development Zone Long Chun Road No. 11 Building 1 floor 2 No. A2 Patentee before: ZHENGZHOU AISIYA BIOTECHNOLOGY CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a primer probe, a kit for detecting cervical cancer oncogene and a detection method for non detecting disease purposes Effective date of registration: 20210319 Granted publication date: 20141029 Pledgee: Bank of China Limited Zhengzhou Airport Branch Pledgor: ZHENGZHOU KODIA BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980001859 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210914 Granted publication date: 20141029 Pledgee: Bank of China Limited Zhengzhou Airport Branch Pledgor: ZHENGZHOU KODIA BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980001859 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a primer probe and a kit for detecting cervical cancer oncogene and a detection method for non disease detection purposes Effective date of registration: 20210916 Granted publication date: 20141029 Pledgee: Bank of China Limited Zhengzhou Airport Branch Pledgor: ZHENGZHOU KODIA BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980009458 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230426 Granted publication date: 20141029 Pledgee: Bank of China Limited Zhengzhou Airport Branch Pledgor: ZHENGZHOU KODIA BIOTECHNOLOGY CO.,LTD. Registration number: Y2021980009458 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A primer probe, reagent kit, and detection method for detecting cervical cancer oncogenic genes for non disease detection purposes Effective date of registration: 20230426 Granted publication date: 20141029 Pledgee: Bank of China Limited Zhengzhou Airport Branch Pledgor: ZHENGZHOU KODIA BIOTECHNOLOGY CO.,LTD. Registration number: Y2023980039447 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |